Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)

NCT01105936 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Paracetamol
DRUG: Placebo

Sponsor

GlaxoSmithKline